L Paul Berns
Affiliations
- See Remarks at Neumora Therapeutics Inc. (NMRA), 2025-05-30
- at Metsera Inc. (MTSR), 2025-05-22
- at Unity Biotechnology Inc. (UBX), 2024-06-21
- Director at Eqrx Inc. (EQRX), 2023-11-09
- Director at Jazz Pharmaceuticals Plc (JAZZ), 2021-08-09
- Director at Menlo Therapeutics Inc. (MNLO), 2019-08-09
- President And Ceo at Anacor Pharmaceuticals Inc. (ANAC), 2016-06-24
- Director at Xenoport Inc (XNPT), 2016-05-19
- Director at Cellectar Biosciences Inc. (CLRB), 2016-04-21
- Chief Executive Officer at Allos Therapeutics Inc (ALTH), 2012-09-05
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| MTSR | $18.00 | 789,998 | $14,219,964.00 | 8,313,680 | 2025-02-03 | Filing |
| CLRB | $2.12 | 117,371 | $248,826.52 | 117,371 | 2016-04-20 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| NMRA | $1.69 | 13,871 | $23,468.34 | 7,405,004 | 2025-02-18 | Filing |
| JAZZ | $154.00 | 1,450 | $223,300.00 | 8,290 | 2021-08-05 | Filing |
| JAZZ | $150.90 | 3,825 | $577,185.62 | 9,740 | 2020-11-04 | Filing |
| JAZZ | $149.28 | 400 | $59,711.00 | 13,565 | 2020-11-04 | Filing |
| JAZZ | $147.44 | 466 | $68,707.04 | 13,965 | 2020-11-04 | Filing |